Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Gen 2 Travoprost Intracameral Implant
DRUG
2 trials
Sponsors
Glaukos Corporation
Conditions
Glaucoma
Phase 2
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Recruiting
NCT07075718
Glaukos Corporation
Glaucoma
Start: 2025-06-12
End: 2032-03-01
Target: 610
Updated: 2026-03-02
Phase 3
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Recruiting
NCT07495852
Glaukos Corporation
Glaucoma
Start: 2026-02-17
End: 2032-03-01
Target: 510
Updated: 2026-03-30